Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Other Non-Current Liabilities (2021 - 2025)

BioAtla's Other Non-Current Liabilities history spans 5 years, with the latest figure at $3.5 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities fell 7.74% year-over-year to $3.5 million; the TTM value through Dec 2025 reached $3.5 million, down 7.74%, while the annual FY2025 figure was $3.5 million, 7.74% down from the prior year.
  • Other Non-Current Liabilities reached $3.5 million in Q4 2025 per BCAB's latest filing, down from $4.3 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $19.8 million in Q4 2021 to a low of $3.5 million in Q4 2025.
  • Average Other Non-Current Liabilities over 5 years is $17.0 million, with a median of $19.8 million recorded in 2021.
  • Peak YoY movement for Other Non-Current Liabilities: changed 0.0% in 2022, then crashed 80.76% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $19.8 million in 2021, then changed by 0.0% to $19.8 million in 2022, then changed by 0.0% to $19.8 million in 2023, then plummeted by 80.76% to $3.8 million in 2024, then dropped by 7.74% to $3.5 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Other Non-Current Liabilities are $3.5 million (Q4 2025), $4.3 million (Q3 2025), and $19.8 million (Q2 2025).